联合王国禁止为误导性索赔和安全风险在社交媒体上刊登减肥药物广告。 UK bans weight-loss drug ads on social media for misleading claims and safety risks.

英国广告标准管理局禁止Chequp、SkinnyJab和MedExpress提供处方减肥药品的社交媒体广告, 裁定他们违反广告规则, The UK's Advertising Standards Authority has banned social media ads for prescription weight-loss drugs from Chequp, SkinnyJab, and MedExpress, ruling they violated advertising rules by exploiting body image insecurities and promoting potentially unsafe treatments to the public. 这些广告出现在Instagram和TikTok等平台上, 受到批评, 因为他们迫使新妈妈在产后减肥、污名化大身体、不披露健康风险, The ads, which appeared on platforms like Instagram and TikTok, were criticized for pressuring new mothers to lose weight postpartum, stigmatizing larger bodies, and failing to disclose health risks, especially for breastfeeding individuals. ASA强调,只开处方的药品不能向消费者宣传,执法行动是与卫生监管者一道打击误导性减重宣传的更广泛努力的一部分。 The ASA emphasized that prescription-only medicines cannot be advertised to consumers, and the enforcement action is part of a broader effort with health regulators to combat misleading weight-loss promotions. 所有公司都删除了广告,并正在审查其营销做法。 All companies have removed the ads and are reviewing their marketing practices.